Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Everest Medicines Announces Approval of Trodelvy® in China for Second-Line Metastatic Triple-Negative Breast Cancer
2022-06-10 11:12
Mentice AB acquires all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.
2022-06-10 04:59
Mentice AB completes a directed new share issue of approximately SEK 60 million which was significantly oversubscribed
2022-06-10 04:47
Mentice AB intends to acquire all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.
2022-06-10 00:48
Inteleos Announces Maya Health Alliance as MissionPOCUS Selection for 2022
2022-06-09 22:17
Brii Biosciences Announces Positive Data from a Randomized, Single-Blind Study of its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China
2022-06-09 19:00
Nippon Express Launches Ultra-low Temperature-controlled Logistics Service for Pharmaceutical Industry
2022-06-09 15:00
Sciwind Biosciences to present Data from its GLP-1 and GIP Receptor Agonist Programs at The International Liver Congress(TM) EASL 2022
2022-06-09 08:00
Prenetics Launches ColoClear, a Non-Invasive Stool DNA Test to Detect Early Signs of Colorectal Cancer in Hong Kong
2022-06-09 00:56
Medison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of KIMMTRAK® (tebentafusp) for the Treatment of Unresectable or Metastatic Uveal Melanoma
2022-06-08 23:54
Havas Health & You Appoints Industry Veteran David Leonardi as Chief Creative Officer of Havas Tonic
2022-06-08 21:00
Indonesia's G20 HWG Meeting Series Urges World Leaders to Be Prepared for Future Pandemics
2022-06-08 20:50
New app from Health in Transportation & NuraLogix allows drivers to perform CDL health checks that target hypertension and type-2 diabetes.
2022-06-08 20:15
Gannex Announces U.S. FDA Clearance of Clinical Trial on FXR Agonist ASC42 for Treatment of Primary Biliary Cholangitis
2022-06-08 20:10
UTSA awards $4 million to Oskar Fischer Prize recipients for innovative explanations of Alzheimer's disease
2022-06-08 20:05
Hong Kong Women's Powerlifting Champion Launches Performance-Focused Activewear Line
2022-06-08 14:33
Dr Aaron Poh shares Advanced Surgical Techniques for Colorectal Cancer, the Top 3 Most Common Cancer Worldwide
2022-06-08 10:00
FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older
2022-06-08 09:23
Antengene Announces First Patient Dosed in the Phase I STAMINA-001 Study of ATG-037 for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors
2022-06-08 08:30
First Patient Enrolled in SELUTION SLR IDE BTK Study
2022-06-08 08:00
1
194
195
196
197
198
739